Thomas Zander

4PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial.

Yelena Y Janjigian, Jaffer A Ajani, Markus Moehler

|Oct 14, 2022
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic.

Volker Arndt, Daniela Doege, Stefan Fröhling

Pageof 1